Trial NCT04411667
Publication Sakoulas G, medRxiv, 2020
Dates: 2020-05-01 to 2020-06-16
Funding: Private (IVIG (Octagam 10%) was provided by Octapharma USA, Hoboken, NJ)
Conflict of interest: no COI